,i  #aaf? ,,congress  #a/ ,session  ,h4 
,r4 #bbji  ,,9 ,,! ,,h\se ,,(           
,,repres5tatives  ,april #aj1 #bjai ,mr4
 ,mead[s introduc$ ! foll[+ bill2 :i* 0 
ref]r$ to ! ,committee on ,ways & ,means
  ,a ,,bill  ,to e/abli% ! position (   
,*ief ,ph>maceutical ,negotiator 9 !    
,(fice ( ! ,unit$ ,/ates ,trade         
,repres5tative responsible = conduct+   
trade negotiations & en=c+ trade        
agreem5ts relat$ to acts1 policies1 &   
practices ( =eign gov]nm5ts t fail to   
appropriately rew>d ,unit$ ,/ates       
innovation ) respect to ph>maceuticals1 
& = o!r purposes4  #a4 ,%ort title ,?is 
,act may be cit$ z ! ,fix+ ,global      
,freeload+ ,act4  #b4 ,f9d+s ,congress  
f9ds ! foll[+3  7#a7 ,int]national      
gov]nm5t price controls ( ph>maceutical 
products & s]vices creates an unfair    
play+ field because ! re/ ( ! _w relies 
on & b5efits f ! bioph>maceutical       
innovation t takes place 9 ! ,unit$     
,/ates1 :i* supports #d4e million jobs &
 am\nts to #ij billion 9 rese>* &       

developm5t inve/m5t e ye>4  7#b7 ,!     
,unit$ ,/ates pays ! co/ ( develop+     
innovative & life-sav+ prescription     
drugs :ile o!r c\ntries refuse to pay _!
 fair %>e = _! heal? c>e ne$s4  7#c7 ,9 
fact1 "s ( ! ,unit$ ,/ates trad+ p>tn]s 
are ignor+ obligations e/abli%$ "u trade
 agreem5ts & sett+ up discrim9atory     
rules to b5efit local competitors ov]   
,unit$ ,/ates companies4  7#d7 ,betwe5  
#bjaj & #bjaa1 #bc c\ntries implem5t$   
#hi di/9ct measures to conta9 gov]nm5t  
sp5d+ on prescription drugs4 ,mo/ us$ _!
 s+le-pay] heal?c>e sy/ems to impose    
drug price controls alongside increas$  
copaym5ts1 value-add$ tax rates on      
prescription drugs1 & o!r measures4     
7#e7 ,/udies h %[n t gov]nm5t price     
controls result 9 prices bel[ actual    
m>ket value & pu% ! burd5 ( pay+ =      
innovative treatm5ts on to ,unit$ ,/ates
 pati5ts4  #c4 ,*ief ,ph>maceutical     
,negotiator  7a7 ,9 g5]al ,section #ada 
( ! ,trade ,act ( #aigd 7#ai ,u4,s4,c4  
#baga7 is am5d$--  7#a7 9 subsection    

7b77#b7-- 7,a7 by /rik+ & "o ,*ief      
,innovation & ,intellectual ,prop]ty    
,negotiator & ins]t+ "o ,*ief           
,innovation & ,intellectual ,prop]ty    
,negotiator1 & "o ,*ief ,ph>maceutical  
,negotiator2  7,b7 by /rik+ or ! ,*ief  
,innovation & ,intellectual ,prop]ty    
,negotiator & ins]t+ ! ,*ief ,innovation
 & ,intellectual ,prop]ty ,negotiator1  
or ! ,*ief ,ph>maceutical ,negotiator2 &
  7,c7 by /rik+ & ! ,*ief ,innovation & 
,intellectual ,prop]ty ,negotiator &    
ins]t+ ! ,*ief ,innovation &            
,intellectual ,prop]ty ,negotiator1 & ! 
,*ief ,ph>maceutical ,negotiator2 &     
7#b7 9 subsection 7c71 by add+ at ! end 
! foll[+ new p>agraph3  7#g7 ,! pr9cipal
 function ( ! ,*ief ,ph>maceutical      
,negotiator %all be to conduct trade    
negotiations & to en=ce trade agreem5ts 
relat+ to ,unit$ ,/ates ph>maceutical   
products & s]vices4 ,! ,*ief            
,ph>maceutical ,negotiator %all be a    
vigor\s advocate on behalf ( ,unit$     
,/ates ph>maceutical int]e/s4 ,! ,*ief  

,ph>maceutical ,negotiator %all p]=m su*
 o!r functions z ! ,unit$ ,/ates ,trade 
,repres5tative may direct4  4  7b7      
,comp5sation ,section #ecad ( title #e1 
,unit$ ,/ates ,code is am5d$ by /rik+   
,*ief ,innovation & ,intellectual       
,prop]ty ,negotiator1 ,(fice ( ! ,unit$ 
,/ates ,trade ,repres5tative4 & ins]t+ !
 foll[+3  ,*ief ,innovation &           
,intellectual ,prop]ty ,negotiator1     
,(fice ( ! ,unit$ ,/ates ,trade         
,repres5tative4  ,*ief ,ph>maceutical   
,negotiator1 ,(fice ( ! ,unit$ ,/ates   
,trade ,repres5tative4  4  7c7 ,report  
requir$ ,n lat] ?an "o ye> aft] !       
appo9tm5t ( ! fir/ ,*ief ,ph>maceutical 
,negotiator pursuant to p>agraph 7#b7 ( 
section #ada7;b7 ( ! ,trade ,act (      
#aigd1 z am5d$ by subsection 7a71 &     
annually !reaft]1 ! ,unit$ ,/ates ,trade
 ,repres5tative %all submit to !        
,committee on ,f9ance ( ! ,s5ate & !    
,committee on ,ways & ,means ( ! ,h\se (
 ,repres5tatives a report describ+ 9    
detail--  7#a7 en=cem5t actions tak5 by 

! ,trade ,repres5tative dur+ ! "o-ye>   
p]iod prec$+ ! submission ( ! report to 
ensure ! protection ( ,unit$ ,/ates     
ph>maceutical products & s]vices2 &     
7#b7 o!r actions tak5 by ! ,trade       
,repres5tative to advance ,unit$ ,/ates 
ph>maceutical products & s]vices4